Stock Earnings

Question 1

Acrivon Therapeutics Incの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Acrivon Therapeutics Incの総資産は$196で、純lossは$-80です。

Question 2

ACRVの主要な財務比率は何ですか？

Accepted Answer

Acrivon Therapeutics Incの流動比率は10.31、純利益率は0、1株当たり売上高は$0です。

Question 3

Acrivon Therapeutics Incの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Acrivon Therapeutics Inc data is not available.

Question 4

Acrivon Therapeutics Incは収益を上げていますか？

Accepted Answer

no、最新の財務諸表によると、Acrivon Therapeutics Incの純lossは$-80です。

Question 5

Acrivon Therapeutics Incに負債はありますか？

Accepted Answer

yes、Acrivon Therapeutics Incの負債は19です。

Question 6

Acrivon Therapeutics Incの発行済株式数は何株ですか？

Accepted Answer

Acrivon Therapeutics Incの総発行済株式数は31.23株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	25	25	21	8	2	1
Research & Development	69	63	46	23	13	1
Operating Expenses	94	89	67	32	16	3
Other Non Operating Income (Expenses)	0	0	6	1	0	0
Pretax Income	-85	-80	-60	-31	-16	-5
Income Tax Expense	--	--	--	--	--	--
Net Income	-85	-80	-60	-31	-16	-5
Net Income Growth	23%	33%	94%	94%	220%	--
Shares Outstanding (Diluted)	38.46	33.79	22.07	21.92	20.86	20.86
Shares Change (YoY)	6%	53%	1%	5%	0%	--
EPS (Diluted)	-2.24	-2.38	-2.73	-1.42	-0.78	-0.25
EPS Growth	18%	-13%	93%	82%	212%	--
Free Cash Flow	-73	-68	-43	-32	-14	-2
Free Cash Flow Per Share	-1.89	-2.01	-1.94	-1.45	-0.67	-0.09
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-93	-88	-67	-32	-16	-3
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	-94	-89	-67	-32	-16	-3
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Acrivon Therapeutics Inc (ACRV) Price